nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Nephrotoxicity—Adefovir Dipivoxil—hepatitis B	0.0214	0.035	CcSEcCtD
Etoricoxib—Sciatica—Telbivudine—hepatitis B	0.02	0.0328	CcSEcCtD
Etoricoxib—MAPK14—blood plasma—hepatitis B	0.0159	0.189	CbGeAlD
Etoricoxib—Nephropathy toxic—Adefovir Dipivoxil—hepatitis B	0.0118	0.0194	CcSEcCtD
Etoricoxib—Platelet count decreased—Entecavir—hepatitis B	0.0117	0.0192	CcSEcCtD
Etoricoxib—Serum creatinine increased—Entecavir—hepatitis B	0.0113	0.0185	CcSEcCtD
Etoricoxib—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.011	0.0181	CcSEcCtD
Etoricoxib—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.0109	0.0178	CcSEcCtD
Etoricoxib—Skin infection—Lamivudine—hepatitis B	0.0107	0.0175	CcSEcCtD
Etoricoxib—Hepatic steatosis—Lamivudine—hepatitis B	0.0107	0.0175	CcSEcCtD
Etoricoxib—Glycosuria—Entecavir—hepatitis B	0.0086	0.0141	CcSEcCtD
Etoricoxib—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00839	0.0137	CcSEcCtD
Etoricoxib—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00831	0.0136	CcSEcCtD
Etoricoxib—CYP2C19—blood plasma—hepatitis B	0.00674	0.0804	CbGeAlD
Etoricoxib—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00668	0.0109	CcSEcCtD
Etoricoxib—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00613	0.01	CcSEcCtD
Etoricoxib—MAPK14—blood—hepatitis B	0.00581	0.0693	CbGeAlD
Etoricoxib—Musculoskeletal pain—Telbivudine—hepatitis B	0.00579	0.00948	CcSEcCtD
Etoricoxib—Neck pain—Telbivudine—hepatitis B	0.00579	0.00948	CcSEcCtD
Etoricoxib—Hepatic failure—Entecavir—hepatitis B	0.00562	0.00921	CcSEcCtD
Etoricoxib—Vemurafenib—ALB—hepatitis B	0.00561	0.478	CrCbGaD
Etoricoxib—CYP1A2—blood plasma—hepatitis B	0.00551	0.0656	CbGeAlD
Etoricoxib—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00549	0.00898	CcSEcCtD
Etoricoxib—CYP2C9—blood plasma—hepatitis B	0.00523	0.0623	CbGeAlD
Etoricoxib—Anaphylactoid reaction—Entecavir—hepatitis B	0.00522	0.00855	CcSEcCtD
Etoricoxib—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00518	0.00848	CcSEcCtD
Etoricoxib—Folliculitis—Lamivudine—hepatitis B	0.00513	0.0084	CcSEcCtD
Etoricoxib—CYP2E1—blood plasma—hepatitis B	0.00495	0.059	CbGeAlD
Etoricoxib—Blood creatinine increased—Entecavir—hepatitis B	0.00474	0.00775	CcSEcCtD
Etoricoxib—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00468	0.00767	CcSEcCtD
Etoricoxib—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00462	0.00756	CcSEcCtD
Etoricoxib—PTGS2—blood plasma—hepatitis B	0.00456	0.0544	CbGeAlD
Etoricoxib—MAPK14—liver—hepatitis B	0.00454	0.0542	CbGeAlD
Etoricoxib—Renal impairment—Telbivudine—hepatitis B	0.00436	0.00714	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00435	0.00712	CcSEcCtD
Etoricoxib—Pancreatitis—Entecavir—hepatitis B	0.00428	0.00701	CcSEcCtD
Etoricoxib—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00418	0.00684	CcSEcCtD
Etoricoxib—Pain in extremity—Telbivudine—hepatitis B	0.00415	0.0068	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Entecavir—hepatitis B	0.00406	0.00665	CcSEcCtD
Etoricoxib—CYP3A4—blood plasma—hepatitis B	0.00399	0.0475	CbGeAlD
Etoricoxib—Hyperglycaemia—Entecavir—hepatitis B	0.00394	0.00645	CcSEcCtD
Etoricoxib—CYP2D6—blood plasma—hepatitis B	0.00392	0.0468	CbGeAlD
Etoricoxib—Renal failure—Entecavir—hepatitis B	0.00383	0.00627	CcSEcCtD
Etoricoxib—Cramp muscle—Telbivudine—hepatitis B	0.00374	0.00612	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00374	0.00612	CcSEcCtD
Etoricoxib—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00374	0.00612	CcSEcCtD
Etoricoxib—Haematuria—Entecavir—hepatitis B	0.00371	0.00608	CcSEcCtD
Etoricoxib—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0037	0.00606	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Entecavir—hepatitis B	0.00368	0.00603	CcSEcCtD
Etoricoxib—Gastritis—Telbivudine—hepatitis B	0.00367	0.00602	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00366	0.00599	CcSEcCtD
Etoricoxib—Muscular weakness—Telbivudine—hepatitis B	0.00366	0.00599	CcSEcCtD
Etoricoxib—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00362	0.00593	CcSEcCtD
Etoricoxib—Abdominal distension—Telbivudine—hepatitis B	0.00361	0.00591	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00359	0.00588	CcSEcCtD
Etoricoxib—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00357	0.00584	CcSEcCtD
Etoricoxib—Hepatitis—Entecavir—hepatitis B	0.0035	0.00572	CcSEcCtD
Etoricoxib—Oedema peripheral—Entecavir—hepatitis B	0.00344	0.00564	CcSEcCtD
Etoricoxib—Abdominal discomfort—Telbivudine—hepatitis B	0.00344	0.00563	CcSEcCtD
Etoricoxib—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00341	0.00558	CcSEcCtD
Etoricoxib—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00339	0.00554	CcSEcCtD
Etoricoxib—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00337	0.00552	CcSEcCtD
Etoricoxib—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00335	0.00549	CcSEcCtD
Etoricoxib—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00334	0.00547	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00334	0.00546	CcSEcCtD
Etoricoxib—Celecoxib—ALB—hepatitis B	0.0033	0.281	CrCbGaD
Etoricoxib—Musculoskeletal pain—Lamivudine—hepatitis B	0.00326	0.00534	CcSEcCtD
Etoricoxib—Immune system disorder—Entecavir—hepatitis B	0.00316	0.00517	CcSEcCtD
Etoricoxib—Renal failure—Telbivudine—hepatitis B	0.00315	0.00515	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Telbivudine—hepatitis B	0.00314	0.00513	CcSEcCtD
Etoricoxib—Alopecia—Entecavir—hepatitis B	0.00309	0.00506	CcSEcCtD
Etoricoxib—Mental disorder—Entecavir—hepatitis B	0.00306	0.00501	CcSEcCtD
Etoricoxib—Malnutrition—Entecavir—hepatitis B	0.00304	0.00498	CcSEcCtD
Etoricoxib—Neuropathy—Lamivudine—hepatitis B	0.00303	0.00495	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Telbivudine—hepatitis B	0.00303	0.00495	CcSEcCtD
Etoricoxib—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00297	0.00486	CcSEcCtD
Etoricoxib—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00293	0.00479	CcSEcCtD
Etoricoxib—Mouth ulceration—Lamivudine—hepatitis B	0.00291	0.00477	CcSEcCtD
Etoricoxib—Hepatitis—Telbivudine—hepatitis B	0.00287	0.0047	CcSEcCtD
Etoricoxib—Hypoaesthesia—Telbivudine—hepatitis B	0.00286	0.00468	CcSEcCtD
Etoricoxib—Pharyngitis—Telbivudine—hepatitis B	0.00285	0.00467	CcSEcCtD
Etoricoxib—Vismodegib—ALB—hepatitis B	0.00282	0.241	CrCbGaD
Etoricoxib—Connective tissue disorder—Telbivudine—hepatitis B	0.00282	0.00462	CcSEcCtD
Etoricoxib—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00275	0.00449	CcSEcCtD
Etoricoxib—Gastroenteritis—Lamivudine—hepatitis B	0.00264	0.00432	CcSEcCtD
Etoricoxib—Cough—Adefovir Dipivoxil—hepatitis B	0.00259	0.00424	CcSEcCtD
Etoricoxib—Mediastinal disorder—Telbivudine—hepatitis B	0.00259	0.00424	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00257	0.00421	CcSEcCtD
Etoricoxib—Injury—Lamivudine—hepatitis B	0.00255	0.00417	CcSEcCtD
Etoricoxib—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00253	0.00414	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00251	0.00411	CcSEcCtD
Etoricoxib—Malnutrition—Telbivudine—hepatitis B	0.0025	0.00409	CcSEcCtD
Etoricoxib—Anaphylactic shock—Entecavir—hepatitis B	0.00248	0.00407	CcSEcCtD
Etoricoxib—CYP2C19—blood—hepatitis B	0.00247	0.0294	CbGeAlD
Etoricoxib—Infection—Entecavir—hepatitis B	0.00247	0.00404	CcSEcCtD
Etoricoxib—Renal impairment—Lamivudine—hepatitis B	0.00246	0.00403	CcSEcCtD
Etoricoxib—Thirst—Lamivudine—hepatitis B	0.00246	0.00403	CcSEcCtD
Etoricoxib—Dysgeusia—Telbivudine—hepatitis B	0.00245	0.00401	CcSEcCtD
Etoricoxib—Nervous system disorder—Entecavir—hepatitis B	0.00244	0.00399	CcSEcCtD
Etoricoxib—Skin disorder—Entecavir—hepatitis B	0.00241	0.00395	CcSEcCtD
Etoricoxib—Muscle spasms—Telbivudine—hepatitis B	0.0024	0.00394	CcSEcCtD
Etoricoxib—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00238	0.00389	CcSEcCtD
Etoricoxib—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00237	0.00388	CcSEcCtD
Etoricoxib—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00235	0.00385	CcSEcCtD
Etoricoxib—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00231	0.00378	CcSEcCtD
Etoricoxib—Insomnia—Entecavir—hepatitis B	0.00225	0.00368	CcSEcCtD
Etoricoxib—Somnolence—Entecavir—hepatitis B	0.00221	0.00362	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00221	0.00362	CcSEcCtD
Etoricoxib—Dyspepsia—Entecavir—hepatitis B	0.00219	0.00358	CcSEcCtD
Etoricoxib—Cough—Telbivudine—hepatitis B	0.00218	0.00357	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Entecavir—hepatitis B	0.00214	0.00351	CcSEcCtD
Etoricoxib—Fatigue—Entecavir—hepatitis B	0.00214	0.00351	CcSEcCtD
Etoricoxib—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00213	0.00349	CcSEcCtD
Etoricoxib—Arthralgia—Telbivudine—hepatitis B	0.00213	0.00348	CcSEcCtD
Etoricoxib—Chest pain—Telbivudine—hepatitis B	0.00213	0.00348	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00211	0.00346	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00211	0.00345	CcSEcCtD
Etoricoxib—Cramp muscle—Lamivudine—hepatitis B	0.00211	0.00345	CcSEcCtD
Etoricoxib—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00211	0.00345	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00209	0.00343	CcSEcCtD
Etoricoxib—Muscular weakness—Lamivudine—hepatitis B	0.00206	0.00338	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00206	0.00338	CcSEcCtD
Etoricoxib—Abdominal distension—Lamivudine—hepatitis B	0.00204	0.00333	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Entecavir—hepatitis B	0.00203	0.00333	CcSEcCtD
Etoricoxib—CYP1A2—blood—hepatitis B	0.00202	0.024	CbGeAlD
Etoricoxib—Nervous system disorder—Telbivudine—hepatitis B	0.002	0.00328	CcSEcCtD
Etoricoxib—Thrombocytopenia—Telbivudine—hepatitis B	0.002	0.00327	CcSEcCtD
Etoricoxib—Pancreatitis—Lamivudine—hepatitis B	0.00198	0.00325	CcSEcCtD
Etoricoxib—Skin disorder—Telbivudine—hepatitis B	0.00198	0.00325	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00198	0.00324	CcSEcCtD
Etoricoxib—Abdominal pain—Entecavir—hepatitis B	0.00196	0.00321	CcSEcCtD
Etoricoxib—Bronchitis—Lamivudine—hepatitis B	0.00195	0.00318	CcSEcCtD
Etoricoxib—Abdominal discomfort—Lamivudine—hepatitis B	0.00194	0.00317	CcSEcCtD
Etoricoxib—CYP2C19—liver—hepatitis B	0.00193	0.023	CbGeAlD
Etoricoxib—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00192	0.00314	CcSEcCtD
Etoricoxib—CYP2C9—blood—hepatitis B	0.00191	0.0228	CbGeAlD
Etoricoxib—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00186	0.00304	CcSEcCtD
Etoricoxib—Insomnia—Telbivudine—hepatitis B	0.00185	0.00302	CcSEcCtD
Etoricoxib—Hyperglycaemia—Lamivudine—hepatitis B	0.00182	0.00299	CcSEcCtD
Etoricoxib—CYP2E1—blood—hepatitis B	0.00181	0.0216	CbGeAlD
Etoricoxib—Dyspepsia—Telbivudine—hepatitis B	0.0018	0.00294	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00179	0.00293	CcSEcCtD
Etoricoxib—Asthenia—Entecavir—hepatitis B	0.00178	0.00292	CcSEcCtD
Etoricoxib—Renal failure—Lamivudine—hepatitis B	0.00177	0.0029	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Lamivudine—hepatitis B	0.00177	0.00289	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00176	0.00288	CcSEcCtD
Etoricoxib—Fatigue—Telbivudine—hepatitis B	0.00176	0.00288	CcSEcCtD
Etoricoxib—Stomatitis—Lamivudine—hepatitis B	0.00176	0.00288	CcSEcCtD
Etoricoxib—Jaundice—Lamivudine—hepatitis B	0.00176	0.00288	CcSEcCtD
Etoricoxib—Pain—Telbivudine—hepatitis B	0.00175	0.00286	CcSEcCtD
Etoricoxib—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00174	0.00285	CcSEcCtD
Etoricoxib—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00171	0.00281	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Lamivudine—hepatitis B	0.00171	0.00279	CcSEcCtD
Etoricoxib—Epistaxis—Lamivudine—hepatitis B	0.0017	0.00278	CcSEcCtD
Etoricoxib—Diarrhoea—Entecavir—hepatitis B	0.0017	0.00278	CcSEcCtD
Etoricoxib—Sinusitis—Lamivudine—hepatitis B	0.00169	0.00277	CcSEcCtD
Etoricoxib—Feeling abnormal—Telbivudine—hepatitis B	0.00168	0.00275	CcSEcCtD
Etoricoxib—PTGS2—blood—hepatitis B	0.00167	0.0199	CbGeAlD
Etoricoxib—Gastrointestinal pain—Telbivudine—hepatitis B	0.00167	0.00273	CcSEcCtD
Etoricoxib—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00166	0.00271	CcSEcCtD
Etoricoxib—Dizziness—Entecavir—hepatitis B	0.00164	0.00269	CcSEcCtD
Etoricoxib—Hepatitis—Lamivudine—hepatitis B	0.00162	0.00265	CcSEcCtD
Etoricoxib—Abdominal pain—Telbivudine—hepatitis B	0.00161	0.00264	CcSEcCtD
Etoricoxib—Hypoaesthesia—Lamivudine—hepatitis B	0.00161	0.00264	CcSEcCtD
Etoricoxib—Pharyngitis—Lamivudine—hepatitis B	0.00161	0.00263	CcSEcCtD
Etoricoxib—Connective tissue disorder—Lamivudine—hepatitis B	0.00159	0.0026	CcSEcCtD
Etoricoxib—Vomiting—Entecavir—hepatitis B	0.00158	0.00259	CcSEcCtD
Etoricoxib—CYP1A2—liver—hepatitis B	0.00158	0.0188	CbGeAlD
Etoricoxib—Rash—Entecavir—hepatitis B	0.00157	0.00256	CcSEcCtD
Etoricoxib—Dermatitis—Entecavir—hepatitis B	0.00157	0.00256	CcSEcCtD
Etoricoxib—Headache—Entecavir—hepatitis B	0.00156	0.00255	CcSEcCtD
Etoricoxib—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00154	0.00252	CcSEcCtD
Etoricoxib—Erythema multiforme—Lamivudine—hepatitis B	0.00153	0.00251	CcSEcCtD
Etoricoxib—Rash—Adefovir Dipivoxil—hepatitis B	0.00153	0.0025	CcSEcCtD
Etoricoxib—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00153	0.0025	CcSEcCtD
Etoricoxib—Headache—Adefovir Dipivoxil—hepatitis B	0.00152	0.00249	CcSEcCtD
Etoricoxib—CYP2C9—liver—hepatitis B	0.0015	0.0178	CbGeAlD
Etoricoxib—Nausea—Entecavir—hepatitis B	0.00148	0.00242	CcSEcCtD
Etoricoxib—Asthenia—Telbivudine—hepatitis B	0.00146	0.0024	CcSEcCtD
Etoricoxib—Immune system disorder—Lamivudine—hepatitis B	0.00146	0.00239	CcSEcCtD
Etoricoxib—CYP3A4—blood—hepatitis B	0.00146	0.0174	CbGeAlD
Etoricoxib—Mediastinal disorder—Lamivudine—hepatitis B	0.00146	0.00239	CcSEcCtD
Etoricoxib—Pruritus—Telbivudine—hepatitis B	0.00144	0.00236	CcSEcCtD
Etoricoxib—Nausea—Adefovir Dipivoxil—hepatitis B	0.00144	0.00236	CcSEcCtD
Etoricoxib—CYP2D6—blood—hepatitis B	0.00144	0.0171	CbGeAlD
Etoricoxib—Alopecia—Lamivudine—hepatitis B	0.00143	0.00234	CcSEcCtD
Etoricoxib—CYP2E1—liver—hepatitis B	0.00142	0.0169	CbGeAlD
Etoricoxib—Malnutrition—Lamivudine—hepatitis B	0.00141	0.00231	CcSEcCtD
Etoricoxib—Erythema—Lamivudine—hepatitis B	0.00141	0.00231	CcSEcCtD
Etoricoxib—Diarrhoea—Telbivudine—hepatitis B	0.0014	0.00229	CcSEcCtD
Etoricoxib—Flatulence—Lamivudine—hepatitis B	0.00139	0.00227	CcSEcCtD
Etoricoxib—Dysgeusia—Lamivudine—hepatitis B	0.00138	0.00226	CcSEcCtD
Etoricoxib—Muscle spasms—Lamivudine—hepatitis B	0.00135	0.00222	CcSEcCtD
Etoricoxib—Dizziness—Telbivudine—hepatitis B	0.00135	0.00221	CcSEcCtD
Etoricoxib—Tremor—Lamivudine—hepatitis B	0.00132	0.00216	CcSEcCtD
Etoricoxib—PTGS2—liver—hepatitis B	0.00131	0.0156	CbGeAlD
Etoricoxib—Anaemia—Lamivudine—hepatitis B	0.0013	0.00213	CcSEcCtD
Etoricoxib—Vomiting—Telbivudine—hepatitis B	0.0013	0.00212	CcSEcCtD
Etoricoxib—Angioedema—Lamivudine—hepatitis B	0.00129	0.00211	CcSEcCtD
Etoricoxib—Rash—Telbivudine—hepatitis B	0.00129	0.00211	CcSEcCtD
Etoricoxib—Dermatitis—Telbivudine—hepatitis B	0.00129	0.0021	CcSEcCtD
Etoricoxib—Headache—Telbivudine—hepatitis B	0.00128	0.00209	CcSEcCtD
Etoricoxib—Cough—Lamivudine—hepatitis B	0.00123	0.00201	CcSEcCtD
Etoricoxib—Nausea—Telbivudine—hepatitis B	0.00121	0.00198	CcSEcCtD
Etoricoxib—Chest pain—Lamivudine—hepatitis B	0.0012	0.00196	CcSEcCtD
Etoricoxib—Arthralgia—Lamivudine—hepatitis B	0.0012	0.00196	CcSEcCtD
Etoricoxib—Anxiety—Lamivudine—hepatitis B	0.0012	0.00196	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00119	0.00195	CcSEcCtD
Etoricoxib—Dry mouth—Lamivudine—hepatitis B	0.00117	0.00192	CcSEcCtD
Etoricoxib—Confusional state—Lamivudine—hepatitis B	0.00116	0.0019	CcSEcCtD
Etoricoxib—Anaphylactic shock—Lamivudine—hepatitis B	0.00115	0.00188	CcSEcCtD
Etoricoxib—Oedema—Lamivudine—hepatitis B	0.00115	0.00188	CcSEcCtD
Etoricoxib—Infection—Lamivudine—hepatitis B	0.00114	0.00187	CcSEcCtD
Etoricoxib—CYP3A4—liver—hepatitis B	0.00114	0.0136	CbGeAlD
Etoricoxib—Shock—Lamivudine—hepatitis B	0.00113	0.00185	CcSEcCtD
Etoricoxib—Nervous system disorder—Lamivudine—hepatitis B	0.00113	0.00185	CcSEcCtD
Etoricoxib—Thrombocytopenia—Lamivudine—hepatitis B	0.00113	0.00184	CcSEcCtD
Etoricoxib—CYP2D6—liver—hepatitis B	0.00112	0.0134	CbGeAlD
Etoricoxib—Skin disorder—Lamivudine—hepatitis B	0.00112	0.00183	CcSEcCtD
Etoricoxib—Anorexia—Lamivudine—hepatitis B	0.0011	0.00179	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00105	0.00172	CcSEcCtD
Etoricoxib—Insomnia—Lamivudine—hepatitis B	0.00104	0.0017	CcSEcCtD
Etoricoxib—Dyspnoea—Lamivudine—hepatitis B	0.00103	0.00168	CcSEcCtD
Etoricoxib—Somnolence—Lamivudine—hepatitis B	0.00102	0.00167	CcSEcCtD
Etoricoxib—Dyspepsia—Lamivudine—hepatitis B	0.00101	0.00166	CcSEcCtD
Etoricoxib—Decreased appetite—Lamivudine—hepatitis B	0.001	0.00164	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000993	0.00163	CcSEcCtD
Etoricoxib—Fatigue—Lamivudine—hepatitis B	0.000992	0.00162	CcSEcCtD
Etoricoxib—Pain—Lamivudine—hepatitis B	0.000984	0.00161	CcSEcCtD
Etoricoxib—Constipation—Lamivudine—hepatitis B	0.000984	0.00161	CcSEcCtD
Etoricoxib—Feeling abnormal—Lamivudine—hepatitis B	0.000948	0.00155	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Lamivudine—hepatitis B	0.000941	0.00154	CcSEcCtD
Etoricoxib—Urticaria—Lamivudine—hepatitis B	0.000914	0.0015	CcSEcCtD
Etoricoxib—Abdominal pain—Lamivudine—hepatitis B	0.000909	0.00149	CcSEcCtD
Etoricoxib—Hypersensitivity—Lamivudine—hepatitis B	0.000847	0.00139	CcSEcCtD
Etoricoxib—Asthenia—Lamivudine—hepatitis B	0.000825	0.00135	CcSEcCtD
Etoricoxib—Pruritus—Lamivudine—hepatitis B	0.000814	0.00133	CcSEcCtD
Etoricoxib—Diarrhoea—Lamivudine—hepatitis B	0.000787	0.00129	CcSEcCtD
Etoricoxib—Dizziness—Lamivudine—hepatitis B	0.000761	0.00125	CcSEcCtD
Etoricoxib—Vomiting—Lamivudine—hepatitis B	0.000731	0.0012	CcSEcCtD
Etoricoxib—Rash—Lamivudine—hepatitis B	0.000725	0.00119	CcSEcCtD
Etoricoxib—Dermatitis—Lamivudine—hepatitis B	0.000725	0.00119	CcSEcCtD
Etoricoxib—Headache—Lamivudine—hepatitis B	0.000721	0.00118	CcSEcCtD
Etoricoxib—Nausea—Lamivudine—hepatitis B	0.000683	0.00112	CcSEcCtD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—F2—hepatitis B	0.000326	0.00111	CbGpPWpGaD
Etoricoxib—MAPK14—Cell-Cell communication—CTNNB1—hepatitis B	0.000324	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—UBE2L3—hepatitis B	0.000318	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD274—hepatitis B	0.000318	0.00108	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000314	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—CDKN1A—hepatitis B	0.000313	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—hepatitis B	0.000312	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HSPA5—hepatitis B	0.000311	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—hepatitis B	0.000311	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—hepatitis B	0.000306	0.00104	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—CTNNB1—hepatitis B	0.000299	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—NFKB1—hepatitis B	0.000298	0.00102	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—hepatitis B	0.000297	0.00101	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—NFKB1—hepatitis B	0.000295	0.001	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PDCD1—hepatitis B	0.000291	0.000991	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN2A—hepatitis B	0.000291	0.000991	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—NFKB1—hepatitis B	0.00029	0.000987	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000289	0.000983	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.000288	0.000982	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.000287	0.000977	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000285	0.000972	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IFNB1—hepatitis B	0.00028	0.000956	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00028	0.000956	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000279	0.000949	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—hepatitis B	0.000277	0.000944	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—hepatitis B	0.000275	0.000936	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000274	0.000935	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IFNA1—hepatitis B	0.000274	0.000932	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—ALB—hepatitis B	0.000271	0.000923	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNGR1—hepatitis B	0.00027	0.000921	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.00027	0.000921	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—hepatitis B	0.00027	0.000918	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR0B2—hepatitis B	0.000269	0.000916	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—PTEN—hepatitis B	0.000267	0.000911	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000265	0.000904	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—PTEN—hepatitis B	0.000265	0.000902	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—hepatitis B	0.000265	0.000902	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000263	0.000897	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000263	0.000895	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000261	0.000889	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.000261	0.000888	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—hepatitis B	0.00026	0.000886	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—hepatitis B	0.000259	0.000881	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—NFKB1—hepatitis B	0.000256	0.000872	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—hepatitis B	0.000256	0.000871	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—hepatitis B	0.000256	0.000871	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IFNA2—hepatitis B	0.000255	0.000868	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR2—hepatitis B	0.000254	0.000867	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IFNB1—hepatitis B	0.000253	0.00086	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IFNA1—hepatitis B	0.000246	0.000839	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—hepatitis B	0.000245	0.000836	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000244	0.000833	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.00024	0.000816	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000238	0.000812	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN1A—hepatitis B	0.000238	0.00081	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—NFKB1—hepatitis B	0.000236	0.000804	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.000234	0.000797	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000233	0.000793	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MX1—hepatitis B	0.000233	0.000792	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000232	0.000791	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.000232	0.00079	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.000232	0.000789	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—hepatitis B	0.000231	0.000788	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000231	0.000787	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000231	0.000786	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IFNA2—hepatitis B	0.000229	0.000781	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD14—hepatitis B	0.000229	0.000781	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.000225	0.000766	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000223	0.000759	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000222	0.000757	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—hepatitis B	0.000221	0.000752	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN2A—hepatitis B	0.00022	0.000749	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—hepatitis B	0.00022	0.000748	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000219	0.000746	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000219	0.000745	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—hepatitis B	0.000218	0.000741	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000217	0.00074	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SAG—hepatitis B	0.000217	0.000739	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RIT2—hepatitis B	0.000217	0.000739	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.000213	0.000727	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000213	0.000727	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—hepatitis B	0.000213	0.000725	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000208	0.000707	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000203	0.000691	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000203	0.000691	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—hepatitis B	0.000199	0.000678	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APOBEC3G—hepatitis B	0.000198	0.000674	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SAG—hepatitis B	0.000198	0.000674	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000192	0.000656	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00019	0.000649	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000187	0.000637	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HNF4A—hepatitis B	0.000186	0.000635	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000185	0.00063	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	0.000181	0.000616	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.00018	0.000612	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN1A—hepatitis B	0.00018	0.000612	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—NFKB1—hepatitis B	0.000178	0.000608	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—hepatitis B	0.000176	0.000598	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000174	0.000591	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	0.000172	0.000587	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	0.000171	0.000584	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—hepatitis B	0.000169	0.000575	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—CDKN1A—hepatitis B	0.000168	0.000574	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PTEN—hepatitis B	0.000168	0.000573	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—F2—hepatitis B	0.000168	0.000573	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NFKB1—hepatitis B	0.000167	0.00057	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS2—hepatitis B	0.000166	0.000566	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HSPA5—hepatitis B	0.000163	0.000556	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—hepatitis B	0.000162	0.000551	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000158	0.00054	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—hepatitis B	0.000157	0.000536	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DPB1—hepatitis B	0.000154	0.000525	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000153	0.00052	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000152	0.000518	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKR1B1—hepatitis B	0.00015	0.000511	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—hepatitis B	0.000149	0.000507	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000149	0.000506	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000148	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR2—hepatitis B	0.000148	0.000505	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—hepatitis B	0.000148	0.000505	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000148	0.000503	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNB1—hepatitis B	0.000147	0.000501	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GGT2—hepatitis B	0.000144	0.00049	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNA1—hepatitis B	0.000143	0.000489	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKR1B1—hepatitis B	0.000141	0.000481	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—hepatitis B	0.00014	0.000476	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000137	0.000465	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—hepatitis B	0.000136	0.000464	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GGT2—hepatitis B	0.000135	0.000461	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD14—hepatitis B	0.000134	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNA2—hepatitis B	0.000134	0.000455	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000123	0.000419	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—hepatitis B	0.000122	0.000417	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000115	0.000391	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—hepatitis B	0.000114	0.000388	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—hepatitis B	0.000114	0.000387	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—hepatitis B	0.000113	0.000386	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—hepatitis B	0.000112	0.000383	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—hepatitis B	0.000112	0.000381	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CTNNB1—hepatitis B	0.000111	0.000379	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000111	0.000378	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—hepatitis B	0.000111	0.000377	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKR1B1—hepatitis B	0.000109	0.000371	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NFKB1—hepatitis B	0.000108	0.000368	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—hepatitis B	0.000105	0.000358	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GGT2—hepatitis B	0.000104	0.000356	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000101	0.000345	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000101	0.000344	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKR1B1—hepatitis B	0.0001	0.000341	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-A—hepatitis B	0.0001	0.000341	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKR1B1—hepatitis B	9.92e-05	0.000338	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTNNB1—hepatitis B	9.84e-05	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDKN1A—hepatitis B	9.61e-05	0.000327	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GGT2—hepatitis B	9.6e-05	0.000327	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PTEN—hepatitis B	9.59e-05	0.000327	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NFKB1—hepatitis B	9.54e-05	0.000325	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GGT2—hepatitis B	9.51e-05	0.000324	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GOT2—hepatitis B	9.4e-05	0.00032	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—hepatitis B	9.15e-05	0.000312	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—hepatitis B	9.14e-05	0.000312	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—hepatitis B	9e-05	0.000307	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—hepatitis B	8.83e-05	0.000301	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP2A6—hepatitis B	8.71e-05	0.000297	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.64e-05	0.000294	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL10—hepatitis B	8.56e-05	0.000292	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKR1B1—hepatitis B	8.48e-05	0.000289	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—hepatitis B	8.4e-05	0.000286	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP2A6—hepatitis B	8.19e-05	0.000279	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GGT2—hepatitis B	8.13e-05	0.000277	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	8.12e-05	0.000277	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GOT1—hepatitis B	8.11e-05	0.000276	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GOT2—hepatitis B	7.87e-05	0.000268	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GOT2—hepatitis B	7.41e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—hepatitis B	7.27e-05	0.000248	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GGT1—hepatitis B	6.8e-05	0.000232	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GOT1—hepatitis B	6.8e-05	0.000232	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—hepatitis B	6.78e-05	0.000231	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—hepatitis B	6.68e-05	0.000228	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—hepatitis B	6.64e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKR1B1—hepatitis B	6.55e-05	0.000223	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—hepatitis B	6.45e-05	0.00022	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GOT1—hepatitis B	6.4e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GGT1—hepatitis B	6.4e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP2A6—hepatitis B	6.32e-05	0.000215	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GGT2—hepatitis B	6.28e-05	0.000214	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	6.19e-05	0.000211	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—hepatitis B	6.06e-05	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—hepatitis B	5.99e-05	0.000204	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—hepatitis B	5.93e-05	0.000202	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HLA-A—hepatitis B	5.9e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.89e-05	0.000201	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP2A6—hepatitis B	5.82e-05	0.000198	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP2A6—hepatitis B	5.76e-05	0.000196	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—hepatitis B	5.73e-05	0.000195	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GOT2—hepatitis B	5.72e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—F2—hepatitis B	5.7e-05	0.000194	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1A—hepatitis B	5.6e-05	0.000191	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—hepatitis B	5.58e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKB1—hepatitis B	5.56e-05	0.000189	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.38e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GOT2—hepatitis B	5.26e-05	0.000179	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GOT2—hepatitis B	5.21e-05	0.000178	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—hepatitis B	5.14e-05	0.000175	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GGT1—hepatitis B	4.94e-05	0.000168	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GOT1—hepatitis B	4.94e-05	0.000168	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP2A6—hepatitis B	4.93e-05	0.000168	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.59e-05	0.000157	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GOT1—hepatitis B	4.54e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GGT1—hepatitis B	4.54e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GGT1—hepatitis B	4.5e-05	0.000153	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GOT1—hepatitis B	4.5e-05	0.000153	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.5e-05	0.000153	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GOT2—hepatitis B	4.46e-05	0.000152	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.1e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GOT1—hepatitis B	3.85e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GGT1—hepatitis B	3.85e-05	0.000131	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—hepatitis B	3.84e-05	0.000131	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—hepatitis B	3.8e-05	0.00013	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2A6—hepatitis B	3.8e-05	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—hepatitis B	3.7e-05	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1A—hepatitis B	3.62e-05	0.000123	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—hepatitis B	3.61e-05	0.000123	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—hepatitis B	3.61e-05	0.000123	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKB1—hepatitis B	3.59e-05	0.000122	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.5e-05	0.000119	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—hepatitis B	3.49e-05	0.000119	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GOT2—hepatitis B	3.44e-05	0.000117	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—hepatitis B	3.4e-05	0.000116	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—hepatitis B	3.38e-05	0.000115	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1A—hepatitis B	3.3e-05	0.000112	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—hepatitis B	3.29e-05	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—hepatitis B	2.99e-05	0.000102	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GGT1—hepatitis B	2.97e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GOT1—hepatitis B	2.97e-05	0.000101	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—hepatitis B	2.76e-05	9.4e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—hepatitis B	2.73e-05	9.3e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—hepatitis B	2.63e-05	8.95e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—hepatitis B	2.6e-05	8.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—hepatitis B	2.46e-05	8.39e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—hepatitis B	2.41e-05	8.23e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—hepatitis B	2.39e-05	8.16e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—hepatitis B	2.26e-05	7.68e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—hepatitis B	2.06e-05	7.01e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—hepatitis B	2.05e-05	6.97e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—hepatitis B	2e-05	6.82e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—hepatitis B	1.84e-05	6.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—hepatitis B	1.83e-05	6.22e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—hepatitis B	1.58e-05	5.38e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—hepatitis B	1.56e-05	5.32e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—hepatitis B	1.2e-05	4.1e-05	CbGpPWpGaD
